Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx

Laryngoscope

Volumn 118, Issue 12, 2008, Pages 2129-2134

  Walvekar, Rohan R ^a   Li, Ryan J ^a   Gooding, William E ^b   Gibson, Michael K ^c   Heron, Dwight ^d   Johnson, Jonas T ^a   Ferris, Robert L ^a,e  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Biostatistics Facility   (United States)

^c Division of Medical Oncology   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Early; Limited; Oropharyngeal cancer; Squamous cell carcinoma; Surgical therapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; NECK DISSECTION; OROPHARYNX CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PHARYNX CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TONGUE CARCINOMA; TONSIL CANCER; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; COHORT ANALYSIS; FEMALE; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OROPHARYNX TUMOR; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 58149342156     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e3181857950     Document Type: Article

References (26)

1. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26:612-619.
2. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110:1429-1435.
3. Hoffmann M., Gorogh T., Gottschlich S., et al. Human papillomaviruses in head and neck cancer: 8 year-survivalanalysis of 73 patients. Cancer Lett 2005; 218:199-206.
4. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005; 103:1843-1849.
5. Watkinson JC, Owen C., Thompson S., Das Gupta AR, Glaholm J. Conservation surgery in the management of T1 and T2 oropharyngeal squamous cell carcinoma: the Birmingham UK experience. Clin Otolaryngol Allied Sci 2002; 27:541-548.
6. Shimizu K., Inoue H., Saitoh M., et al. Distribution and impact of lymph node metastases in oropharyngeal cancer. Acta Otolaryngol 2006; 126:872-877.
7. National Comprehensive Cancer Network. 2007 NCCN Clinical Practice Guidelines in Oncology Head and Neck Cancers. Available at: http://www.nccn.org. Accessed May 17, 2008.
8. Holsinger FC, McWhorter AJ, Menard M., Garcia D., Laccourreye O. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region. I. Technique, complications, and functional results. Arch Otolaryngol Head Neck Surg 2005; 131:583-591.
9. Galati LT, Myers EN, Johnson JT. Primary surgery as treatment for early squamous cell carcinoma of the tonsil. Head Neck 2000; 22:294-296.
10. Mowry SE, Ho A., Lotempio MM, Sadeghi A., Blackwell KE, Wang MB. Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope 2006; 116:1589-1593.
11. Levi F., Te VC, Randimbison L., Maspoli M., La Vecchia C. Second primary oral and pharyngeal cancers in subjects diagnosed with oral and pharyngeal cancer. Int J Cancer 2006; 119:2702-2704.
12. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
13. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324: 1685-1690.
14. O'Malley BW Jr, Weinstein GS, Snyder W., Hockstein NG. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006; 116:1465-1472.
15. Nguyen NP, Vos P., Smith HJ, et al. Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol 2007; 28:3-8.
16. Carter RL, Barr LC, O'Brien CJ, Soo KC, Shaw HJ. Transcapsular spread of metastatic squamous cell carcinoma from cervical lymph nodes. Am J Surg 1985; 150:495-499.
17. Alvi A., Johnson JT. Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg 1996; 114:65-70.
18. Carter RL, Bliss JM, Soo KC, O'Brien CJ. Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys 1987; 13:825-832.
19. Myers EN, Alvi A. Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends. Laryngoscope 1996; 106:559-567.
20. Johnson JT, Myers EN, Mayernik DG, Nolan TA, Sigler BA, Wagner RL. Adjuvant methotrexate-5-fluorouracil for extracapsular squamous cell carcinoma in cervical metastasis. Laryngoscope 1990; 100:590-592.
21. Forastiere AA, Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New Engl J Med 2003; 349: 2091-2098.
22. Byers RM, Clayman GL, McGill D., et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck 1999; 21: 499-505.
23. Laccourreye O., Hans S., Menard M., Garcia D., Brasnu D., Holsinger FC. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region. II. An analysis of the incidence, related variables, and consequences of local recurrence. Arch Otolaryngol Head Neck Surg 2005; 131:592-599.
24. Selek U., Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 2004; 59: 743-751.
25. Epstein JD, Knight TK, Epstein JB, Bride MA, Nichol MB. Cost of care for early-and late-stage oral and pharyngeal cancer in the California Medicaid population. Head Neck 2008; 30:178-186.
26. Preuss SF, Quante G., Semrau R., Mueller RP, Klussmann JP, Guntinas-Lichius O. An analysis of surgical complications, morbidity, and cost calculation in patients undergoing multimodal treatment for operable oropharyngeal carcinoma. Laryngoscope 2007; 117:101-105.